Early-Stage Cancer Biomarker Detection via Intravascular Nanomachines: Modeling and Analysis

2026-03-11

AI Summary

Current blood-based detection methods struggle to efficiently capture trace levels of early-stage cancer biomarkers within the complex fluidic environment of the vasculature. This work proposes a minimally invasive detection strategy leveraging intravascular nanomachines and introduces, for the first time, a high-fidelity multiscale computational fluid dynamics model that integrates heterogeneous flow fields, size-dependent particle migration, and red blood cell–induced margination effects to more realistically simulate in vivo transport processes. Simulation results reveal that capillaries exhibit the highest detection probability across nanomachines of varying sizes. Moreover, incorporating realistic vascular transport mechanisms—compared to idealized uniform flow assumptions—significantly reduces overall detection efficiency, underscoring the critical importance of accurate physiological modeling in the design of nanoscale diagnostic systems.

Technology Category

• Computer Vision: Medical and Biological Imaging
• Search and Optimization: Sampling/Simulation-based Search
• Intelligent Robots: Multimodal Perception & Sensor Fusion

Application Category

• Graph Algorithms and Modeling for the Web: Efficient manipulation of static and dynamic Web-related graphs
• User Modeling, Personalization and Recommendation: On-Device user modeling, personalization, and recommendation
• Systems and Infrastructure for Web, Mobile and WoT: Virtualization and resource management in Web systems and infrastructures

Abstract

Early detection of cancer is essential for timely diagnosis and improved patient outcomes. Among emerging technologies, intra-body nanoscale communication offers an innovative solution to identify molecular cues within the human bloodstream. This study investigates a minimally invasive approach for early-stage cancer biomarker detection using nanomachines introduced into the bloodstream. To assess the feasibility of this approach, computational simulations are used to emulate the vascular environment and evaluate biomarker detection performance under different physiological conditions. Current modeling approaches often fail to capture essential vascular characteristics, including non-uniform flow structures, size-dependent particle mobility, and particle margination driven by red blood cell interactions. To address these limitations, our study incorporates these factors into the simulation framework and quantifies their individual and combined effects on biomarker detection efficiency. Baseline detection performance is first obtained under uniform flow assumptions, after which introducing realistic vascular transport mechanisms progressively reduces detection probability for all vessel types and nanomachine sizes. Among the considered vessels, capillary consistently achieves the highest detection probability across all nanomachine sizes.

Problem

• early-stage cancer detection
• intravascular nanomachines
• biomarker detection
• vascular transport
• nanoscale communication

Innovation

• intravascular nanomachines
• cancer biomarker detection
• computational modeling
• particle margination
• non-uniform flow